Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Glod

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Current Pharmaceutical Biotechnology|February 10, 2009
Targeting the tumor stroma in cancer therapyKevin Anton, John Glod
Plos One|April 13, 2012
Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretionKevin Anton, Debabrata Banerjee, John Glod
Stem Cells (Dayton, Ohio)|April 8, 2009
Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned mediumHui Gao, Waldemar Priebe, John Glod, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 17, 2020
Update on the Treatment of Medullary Thyroid Carcinoma in Patients with Multiple Endocrine Neoplasia Type 2Maran Ilanchezhian, Sophia Khan, Christian Okafor, et al.
Frontiers in Immunology|March 11, 2022
Adoptive Cell Therapy in Pediatric and Young Adult Solid Tumors: Current Status and Future DirectionsJohn A Ligon, Kristin M Wessel, Nirali N Shah, et al.
Experimental Cell Research|July 17, 2010
Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieuYanique Rattigan, Jing-Mei Hsu, Pravin J Mishra, et al.
Expert Opinion on Biological Therapy|August 2, 2007
The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapySonia C Picinich, Pravin J Mishra, Prasun J Mishra, et al.
Haematologica|February 29, 2012
Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathwaysDaniel J Medina, Lauri Goodell, John Glod, et al.
Children (Basel, Switzerland)|June 24, 2022
Psychosocial Characteristics and Experiences in Patients with Multiple Endocrine Neoplasia Type 2 (MEN2) and Medullary Thyroid Carcinoma (MTC)Robin Lockridge, Sima Bedoya, Taryn Allen, et al.
Neuroscience Letters|July 26, 2011
Macrophages play a key role in early blood brain barrier reformation after hypothermic brain injuryRajeth Koneru, David Kobiler, Shoshona Lehrer, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Current Pharmaceutical Biotechnology|February 10, 2009
Targeting the tumor stroma in cancer therapyKevin Anton, John Glod
Plos One|April 13, 2012
Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretionKevin Anton, Debabrata Banerjee, John Glod
Stem Cells (Dayton, Ohio)|April 8, 2009
Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned mediumHui Gao, Waldemar Priebe, John Glod, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 17, 2020
Update on the Treatment of Medullary Thyroid Carcinoma in Patients with Multiple Endocrine Neoplasia Type 2Maran Ilanchezhian, Sophia Khan, Christian Okafor, et al.
Frontiers in Immunology|March 11, 2022
Adoptive Cell Therapy in Pediatric and Young Adult Solid Tumors: Current Status and Future DirectionsJohn A Ligon, Kristin M Wessel, Nirali N Shah, et al.
Experimental Cell Research|July 17, 2010
Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieuYanique Rattigan, Jing-Mei Hsu, Pravin J Mishra, et al.
Expert Opinion on Biological Therapy|August 2, 2007
The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapySonia C Picinich, Pravin J Mishra, Prasun J Mishra, et al.
Haematologica|February 29, 2012
Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathwaysDaniel J Medina, Lauri Goodell, John Glod, et al.
Children (Basel, Switzerland)|June 24, 2022
Psychosocial Characteristics and Experiences in Patients with Multiple Endocrine Neoplasia Type 2 (MEN2) and Medullary Thyroid Carcinoma (MTC)Robin Lockridge, Sima Bedoya, Taryn Allen, et al.
Neuroscience Letters|July 26, 2011
Macrophages play a key role in early blood brain barrier reformation after hypothermic brain injuryRajeth Koneru, David Kobiler, Shoshona Lehrer, et al.
Pageof 6